Literature DB >> 9369924

Nucleotide sequence variation of human T-lymphotropic virus type II in Vietnam.

H Yoshizaki1, T Nakasone, T Nakasatomi, S Kusagawa, H Sato, T H Nguyen, H A Mai, T L Hoang, Y Takebe, M Honda.   

Abstract

A high rate of human T-lymphotropic virus type II (HTLV-II) infection has been documented in intravenous drug abusers (IVDAs) in South Vietnam. We have investigated the molecular characteristics of the virus and have shown that one HTLV-II subtype is predominant in Ho Chi Minh City. This molecular subtype, HTLV-IIb, was identified in a number of South Vietnamese by nucleotide sequence analysis of the long terminal repeat (LTR) region. HTLV-IIa was not found. These findings suggest that HTLV-IIb is endemic in IVDAs in South Vietnam, although IVDAs in urban areas in North America are predominantly infected with HTLV-IIa.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369924      PMCID: PMC5921508          DOI: 10.1111/j.1349-7006.1997.tb00452.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates.

Authors:  D Zella; A Cavicchini; M Salemi; C Casoli; F Lori; G Achilli; E Cattaneo; V Landini; U Bertazzoni
Journal:  J Gen Virol       Date:  1993-03       Impact factor: 3.891

2.  Nucleotide sequence analysis of human T cell leukemia virus, type II (HTLV-II) isolates.

Authors:  H Takahashi; S W Zhu; S Ijichi; A Vahlne; H Suzuki; W W Hall
Journal:  AIDS Res Hum Retroviruses       Date:  1993-08       Impact factor: 2.205

3.  Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.

Authors:  M Honda; K Matsuo; T Nakasone; Y Okamoto; H Yoshizaki; K Kitamura; W Sugiura; K Watanabe; Y Fukushima; S Haga; Y Katsura; H Tasaka; K Komuro; T Yamada; T Asano; A Yamazaki; S Yamazaki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

4.  Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil.

Authors:  R Ishak; W J Harrington; V N Azevedo; N Eiraku; M O Ishak; J F Guerreiro; S B Santos; T Kubo; C Monken; S Alexander
Journal:  AIDS Res Hum Retroviruses       Date:  1995-07       Impact factor: 2.205

5.  Human soluble IL-6 receptor: its detection and enhanced release by HIV infection.

Authors:  M Honda; S Yamamoto; M Cheng; K Yasukawa; H Suzuki; T Saito; Y Osugi; T Tokunaga; T Kishimoto
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

6.  Complete nucleotide sequence of HTLV-II isolate NRA: comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian i.v. drug users.

Authors:  H Lee; K B Idler; P Swanson; J J Aparicio; K K Chin; J P Lax; M Nguyen; T Mann; G Leckie; A Zanetti
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

7.  Nucleotide sequence of the 3' region of an infectious human T-cell leukemia virus type II genome.

Authors:  K Shimotohno; W Wachsman; Y Takahashi; D W Golde; M Miwa; T Sugimura; I S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Identification of human T cell leukemia virus type IIb infection in the Wayu, an aboriginal population of Colombia.

Authors:  S Ijichi; K Tajima; V Zaninovic; F E Leon-S; Y Katahira; S Sonoda; T Miura; M Hayami; W W Hall
Journal:  Jpn J Cancer Res       Date:  1993-12

9.  Human T-lymphotropic virus type II in Japan.

Authors:  H Yoshizaki; K Kitamura; A Oki; S Yahara; R Yamanaka; Y Fukushima; K Komuro; S Yamazaki; M Honda
Journal:  Jpn J Cancer Res       Date:  1996-01

10.  Detection of HTLV-II-seropositive blood donors in South Vietnam but not in North Vietnam.

Authors:  S Yamamoto; S Nakata; T Nakasone; T Chosa; P Song; D D Duc; B Hien; N X Quang; T N Trinh; T Ono
Journal:  Jpn J Cancer Res       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.